Erasca, Inc.
ERAS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761918
No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Erasca, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 55 | +55 |
| Shares | 0 | 44.2M | +44.2M |
| Value | $0 | $919.8M | +$919.8M |
New holders (55)
Institutions that held Erasca, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (0)
Institutions that held Erasca, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.